The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
Horsman
M R
MR
Overgaard
J
J
Chaplin
D J
DJ
D000818:Animals; D003131:Combined Modality Therapy; D005260:Female; D006830:Hydralazine / Q000627:therapeutic use*; D006979:Hyperthermia, Induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D008811:Mice, Inbred DBA; D008920:Misonidazole / Q000031:analogs & derivatives* / Q000627:therapeutic use
D006830:Hydralazine; C041712:1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol; D008920:Misonidazole